Literature DB >> 6936869

HLA-DRw4 in pemphigus vulgaris patients in Israel.

C Brautbar, M Moscovitz, T Livshits, S Haim, S Hacham-Zadeh, H A Cohen, R Sharon, D Nelken, T Cohen.   

Abstract

Pemphigus vulgaris (PV) is relatively common in Jews. Three HLA antigens were significantly more frequent in 39 Israeli Jewish PV patients than in controls A26 - 59% vs 20%; Bw38 - 61% vs 20%; and DRw4 - 90% vs 38%. The joint occurrence of A26-Bw38-DRw4 was observed in 46% of PV patients and in 10% of controls. Similar results were recently reported for Jews in the Los Angeles area. Yet, when our patient sample was grouped into Ashkenazi and non-Ashkenazi Jews, it was evident that each of the three antigens had a higher frequency both in Ashkenazi patients and controls as compared to non-Ashkenzai. The relative risk for DRw-4 in Ashkenzim was 33.8 as compared to 14.4 in the total sample of Israeli PV patients. The phenotype A26-Bw38-DRw4 was present in 57% of Ashkenazi patients and in 13% of controls. Ashkenazi Jews have the highest prevalence of PV, and HLA associations were strongest with Ashkenazi PV patients. These associations were with three antigens, all of high frequency in that group.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6936869     DOI: 10.1111/j.1399-0039.1980.tb00299.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  9 in total

1.  Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris.

Authors:  A R Ahmed; R Wagner; K Khatri; G Notani; Z Awdeh; C A Alper; E J Yunis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

2.  HLA antigens and risk for development of pemphigus foliaceus (fogo selvagem) in endemic areas of Brazil.

Authors:  J R Moraes; M E Moraes; M Fernandez-Vina; L A Diaz; H Friedman; I T Campbell; R R Alvarez; S A Sampaio; E A Rivitti; P Stastny
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  HLA class II allelic variation and susceptibility to pemphigus vulgaris.

Authors:  S J Scharf; A Friedmann; C Brautbar; F Szafer; L Steinman; G Horn; U Gyllensten; H A Erlich
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

4.  Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region.

Authors:  F Szafer; C Brautbar; E Tzfoni; G Frankel; L Sherman; I Cohen; S Hacham-Zadeh; W Aberer; G Tappeiner; K Holubar
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

5.  Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris.

Authors:  A R Ahmed; E J Yunis; K Khatri; R Wagner; G Notani; Z Awdeh; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

6.  Specific HLA-DQB and HLA-DRB1 alleles confer susceptibility to pemphigus vulgaris.

Authors:  S J Scharf; A Freidmann; L Steinman; C Brautbar; H A Erlich
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  The polyglandular deficiency syndrome: a new variant in Persian Jews.

Authors:  M S Shapiro; R Zamir; E Weiss; J Radnay; L Shenkman
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

8.  The immunoglobulin heavy chain and disease association: application to pemphigus vulgaris.

Authors:  W T Gibson; M A Walter; A R Ahmed; C A Alper; D W Cox
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

9.  Linkage of pemphigus vulgaris antibody to the major histocompatibility complex in healthy relatives of patients.

Authors:  A R Ahmed; A Mohimen; E J Yunis; N M Mirza; V Kumar; E H Beutner; C A Alper
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.